Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

The Lancet Oncology

Volumn 17, Issue 4, 2016, Pages 440-451

  O'Sullivan, Brian ^a   Huang, Shao Hui ^a   Su, Jie ^a   Garden, Adam S ^b   Sturgis, Erich M ^b   Dahlstrom, Kristina ^b   Lee, Nancy ^c   Riaz, Nadeem ^c   Pei, Xin ^c   Koyfman, Shlomo A ^d   Adelstein, David ^d   Burkey, Brian B ^d   Friborg, Jeppe ^e   Kristensen, Claus A ^e   Gothelf, Anita B ^e   Hoebers, Frank ^f   Kremer, Bernd ^f   Speel, Ernst Jan ^f   Bowles, Daniel W ^g   Raben, David ^g   Karam, Sana D ^g   Yu, Eugene ^a   Xu, Wei ^a   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

^e Rigshospitalet   (Denmark)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CORE PROTEIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; EUROPE; FEMALE; HAZARD RATIO; HUMAN; IN SITU HYBRIDIZATION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; MULTICENTER STUDY (TOPIC); NASOPHARYNX CARCINOMA; NONHUMAN; NORTH AMERICA; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; WART VIRUS; BIOSYNTHESIS; CLASSIFICATION; ISOLATION AND PURIFICATION; LYMPH NODE METASTASIS; OROPHARYNX TUMOR; PAPILLOMAVIRIDAE; PATHOGENICITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VIROLOGY;

AGED; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; VIRAL CORE PROTEINS;

EID: 84959215773     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00560-4     Document Type: Article

References (30)

1. 1 Huang, SH, Xu, W, Waldron, J, et al. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33 (2015), 836–845.
2. 2 Dahlstrom, KR, Calzada, G, Hanby, JD, et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer 119 (2013), 81–89.
3. 3 Brizel, DM, Different strokes for different folks: new paradigms for staging oropharynx cancer. J Clin Oncol 33 (2015), 817–818.
4. 4 Edge, S, Byrd, DR, Compton, CC, Fritz, AG, Greene, FL, Trotti, A, Pharynx. AJCC cancer staging manual, 7th edn., 2010, Springer-Verlag, New York, 41–56.
5. 5 Sobin, L, Gospodarowicz, M, Wittekind, C, Pharynx. International Union Against Cancer: TNM classification of malignant tumours, 7th edn., 2010, Wiley-Blackwell, Chichester, 30–38.
6. 6 Wong, K, Huang, SH, O'Sullivan, B, et al. Point-of-care outcome assessment in the cancer clinic: audit of data quality. Radiother Oncol 95 (2010), 339–343.
7. 7 Riaz, N, Setton, J, Tam, M, et al. Patients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer. Oral Oncol 50 (2014), 863–868.
8. 8 Sinha, P, Kallogjeri, D, Gay, H, et al. High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Oral Oncol 51 (2015), 514–520.
9. 9 Pan, JJ, Ng, WT, Zong, JF, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122 (2016), 546–558.
10. 10 Xu, W, Shen, XW, Su, J, O'Sullivan, B, Huang, SH, Refining evaluation methodology on TNM stage system: assessment on HPV-related oropharyngeal cancer. Austin Biom Biostat, 2, 2015, 1014.
11. 11 Huang, SH, Perez-Ordonez, B, Weinreb, I, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 49 (2013), 79–85.
12. 12 Parsons, JT, Mendenhall, WM, Stringer, SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer 94 (2002), 2967–2980.
13. 13 Bourhis, J, Overgaard, J, Audry, H, et al., on behalf of the Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006), 843–854.
14. 14 Pignon, JP, Bourhis, J, Domenge, C, Designé, L, on behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000), 949–955.
15. 15 Bishop, JA, Lewis, JS Jr, Rocco, JW, Faquin, WC, HPV-related squamous cell carcinoma of the head and neck: an update on testing in routine pathology practice. Semin Diagn Pathol 32 (2015), 344–351.
16. 16 El-Naggar, AK, Westra, WH, p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 34 (2012), 459–461.
17. 17 Liu, SZ, Zandberg, DP, Schumaker, LM, Papadimitriou, JC, Cullen, KJ, Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer. Oral Oncol 51 (2015), 862–869.
18. 18 Hong, AM, Martin, A, Armstrong, BK, et al. Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Ann Oncol 24 (2013), 215–219.
19. 19 Keane, FK, Chen, YH, Neville, BA, et al. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era. Cancer 121 (2015), 2594–2602.
20. 20 Goldenberg, D, Begum, S, Westra, WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 30 (2008), 898–903.
21. 21 Morani, AC, Eisbruch, A, Carey, TE, Hauff, SJ, Walline, HM, Mukherji, SK, Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies. J Comput Assist Tomogr 37 (2013), 343–345.
22. 22 Lambin, P, Rios-Velazquez, E, Leijenaar, R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48 (2012), 441–446.
23. 23 Ang, KK, Harris, J, Wheeler, R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363 (2010), 24–35.
24. 24 Gillison, ML, Zhang, Q, Jordan, R, et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30 (2012), 2102–2111.
25. 25 O'Sullivan, B, Brierley, J, Gospodarowicz, M, Prognosis and classification of cancer. O'Sullivan, B, Brierley, J, D'Cruz, A, et al. (eds.) UICC manual of clinical oncology, 9th edn., 2015, Wiley, Chichester, 23–33.
26. 26 O'Sullivan, B, Shah, JP, Head and neck cancer staging and prognosis: perspectives of the UICC and the AJCC. Bernier, J, (eds.) Multimodality management, 2011, Springer, Heidelberg, 135–155.
27. 27 O'Sullivan, B, Huang, SH, Siu, LL, et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 31 (2013), 543–550.
28. 28 Vainshtein, JM, Spector, ME, McHugh, JB, et al. Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. Oral Oncol 50 (2014), 513–519.
29. 29 Rios Velazquez, E, Hoebers, F, Aerts, HJ, et al. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging. Radiother Oncol 113 (2014), 324–330.
30. 30 Sobin, LH, Brierley, J, Gospodarowicz, M, O'Sullivan, B, Wittekind, C, Principles of cancer staging. O'Sullivan, B, Brierley, J, D'Cruz, A, et al. (eds.) UICC manual of clinical oncology, 9th edn., 2015, Wiley, Chichester, 34–39.